Qynapse is excited to participate in MSVirtual2020 to share and discuss innovative and cutting-edge research in the field of Multiple Sclerosis (MS).
Qynapse is thrilled to be part of the Scientific Program of AAIC and the Virtual Exhibition from July 27 to July 31 − to present our latest advances and solutions.
From July 14 – 18th, Qynapse will be part of the 2019 Alzheimer’s Association International Conference® (AAIC®) held in Los Angeles, California
Qynapse took part in the 2019 International Conference on Alzheimer’s & Parkinson’s Disease (AD/PDTM) in Lisbon, Portugal from March 26 – 31st
From July 22– 26th, Qynapse took part in the 2018 Alzheimer’s Association International Conference® (AAIC®) held in Chicago, Illinois
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
- Qynapse solutions help experts build understanding, by quantifying precisely and automatically the brain atrophy of… https://t.co/GLKl3JvpH92 days ago
- World Alzheimer’s Day: Read our article and hear expert opinions on how #neuroimaging and #AI offer new opportuniti… https://t.co/xkNuccUaXD9 days ago
- We were pleased to present new data at #MSVirtual2020 demonstrating how our QyScore® software improves the clinical… https://t.co/D0c8y26YLT14 days ago
- Thank you @ACTRIMS @ECTRIMS for this great meeting and virtual experience ! The #MSVirtual2020 platform remains vie… https://t.co/w7y52msOWA16 days ago
130, rue de Lourmel
75015 Paris – France